Silexan for treatment of anxiety and depression in the context of COVID-19

Detalles Bibliográficos
Autores principales: Bartova, Lucie, Dold, Markus, Fugger, Gernot, Weidenauer, Ana, Rujescu, Dan, Kasper, Siegfried
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. and ECNP. 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946880/
https://www.ncbi.nlm.nih.gov/pubmed/36867894
http://dx.doi.org/10.1016/j.euroneuro.2023.02.015
_version_ 1784892429865844736
author Bartova, Lucie
Dold, Markus
Fugger, Gernot
Weidenauer, Ana
Rujescu, Dan
Kasper, Siegfried
author_facet Bartova, Lucie
Dold, Markus
Fugger, Gernot
Weidenauer, Ana
Rujescu, Dan
Kasper, Siegfried
author_sort Bartova, Lucie
collection PubMed
description
format Online
Article
Text
id pubmed-9946880
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier B.V. and ECNP.
record_format MEDLINE/PubMed
spelling pubmed-99468802023-02-23 Silexan for treatment of anxiety and depression in the context of COVID-19 Bartova, Lucie Dold, Markus Fugger, Gernot Weidenauer, Ana Rujescu, Dan Kasper, Siegfried Eur Neuropsychopharmacol Correspondence Elsevier B.V. and ECNP. 2023-05 2023-02-23 /pmc/articles/PMC9946880/ /pubmed/36867894 http://dx.doi.org/10.1016/j.euroneuro.2023.02.015 Text en © 2023 Elsevier B.V. and ECNP. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Correspondence
Bartova, Lucie
Dold, Markus
Fugger, Gernot
Weidenauer, Ana
Rujescu, Dan
Kasper, Siegfried
Silexan for treatment of anxiety and depression in the context of COVID-19
title Silexan for treatment of anxiety and depression in the context of COVID-19
title_full Silexan for treatment of anxiety and depression in the context of COVID-19
title_fullStr Silexan for treatment of anxiety and depression in the context of COVID-19
title_full_unstemmed Silexan for treatment of anxiety and depression in the context of COVID-19
title_short Silexan for treatment of anxiety and depression in the context of COVID-19
title_sort silexan for treatment of anxiety and depression in the context of covid-19
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9946880/
https://www.ncbi.nlm.nih.gov/pubmed/36867894
http://dx.doi.org/10.1016/j.euroneuro.2023.02.015
work_keys_str_mv AT bartovalucie silexanfortreatmentofanxietyanddepressioninthecontextofcovid19
AT doldmarkus silexanfortreatmentofanxietyanddepressioninthecontextofcovid19
AT fuggergernot silexanfortreatmentofanxietyanddepressioninthecontextofcovid19
AT weidenauerana silexanfortreatmentofanxietyanddepressioninthecontextofcovid19
AT rujescudan silexanfortreatmentofanxietyanddepressioninthecontextofcovid19
AT kaspersiegfried silexanfortreatmentofanxietyanddepressioninthecontextofcovid19

Ejemplares similares